These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 218119

  • 1. Dehydro-digitoxosides of digitoxigenin and digoxigenin: binding to beef heart (Na+ + K+)-ATPase in relation to unchanged digitoxosides.
    Bossaller C, Schmoldt A.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):11-5. PubMed ID: 218119
    [Abstract] [Full Text] [Related]

  • 2. Cleavage of digoxigenin digitoxosides by rat liver microsomes.
    Schmoldt A, Ahsendorf B.
    Eur J Drug Metab Pharmacokinet; 1980 Jan; 5(4):225-32. PubMed ID: 7250146
    [Abstract] [Full Text] [Related]

  • 3. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
    Akera T, Ng YC, Shieh IS, Bero E, Brody TM, Braselton WE.
    Eur J Pharmacol; 1985 May 08; 111(2):147-57. PubMed ID: 2990948
    [Abstract] [Full Text] [Related]

  • 4. Comparative ability of digoxin and an aminosugar cardiac glycoside to bind to and inhibit Na+,K+-adenosine triphosphatase. Effect of potassium.
    Songu-Mize E, Gunter JL, Caldwell RW.
    Biochem Pharmacol; 1989 Nov 01; 38(21):3689-95. PubMed ID: 2557026
    [Abstract] [Full Text] [Related]

  • 5. Binding of dihydrodigitoxin to beef and human cardiac (Na+ + K+)-ATPase: evidence for two binding sites in cell membranes.
    Brown L, Erdmann E.
    Biochem Pharmacol; 1983 Nov 01; 32(21):3183-90. PubMed ID: 6315020
    [Abstract] [Full Text] [Related]

  • 6. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase.
    Brown L, Erdmann E, Thomas R.
    Biochem Pharmacol; 1983 Sep 15; 32(18):2767-74. PubMed ID: 6313008
    [Abstract] [Full Text] [Related]

  • 7. The effect of digitalis glycosides-specific antisera on the binding of the glycosides to (Na+ + K+)-ATPase.
    Bossaller C.
    Arzneimittelforschung; 1981 Sep 15; 31(4):625-8. PubMed ID: 6264929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of 16 beta formylation on Na, K-ATPase inhibition by cardiac glycosides.
    De Pover A, Godfraind T.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov 15; 321(2):135-9. PubMed ID: 6296702
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the affinity of human, beef and cat heart (Na+ + K+)-ATPase for different digitalis derivatives.
    Brown L, Erdmann E.
    Arzneimittelforschung; 1984 Nov 15; 34(10):1314-8. PubMed ID: 6097261
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of binding of the semi-synthetic alpha-methyl-digitoxigenin-glucoside to cardiac (Na+-K+)ATPase.
    Mohr K.
    Biochem Pharmacol; 1983 Mar 01; 32(5):928-30. PubMed ID: 6301505
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The bis- and mono-digitoxosides of digitoxigenin and digoxigenin: metabolites of digitoxin].
    REPKE K.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1959 Mar 01; 237():155-70. PubMed ID: 14437419
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na+,K+-ATPase (α1β1): Methodological considerations.
    Noël F, Azalim P, do Monte FM, Quintas LEM, Katz A, Karlish SJD.
    J Pharmacol Toxicol Methods; 2018 Mar 01; 94(Pt 2):64-72. PubMed ID: 30244071
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.